- Home
- KALA vs FEMY Comparison
KALA vs FEMY Comparison
Compare KALA & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- FEMY
- Stock Information
- Founded
- KALA 2009
- FEMY 2004
- Country
- KALA United States
- FEMY United States
- Employees
- KALA N/A
- FEMY N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- FEMY Medical/Dental Instruments
- Sector
- KALA Health Care
- FEMY Health Care
- Exchange
- KALA Nasdaq
- FEMY Nasdaq
- Market Cap
- KALA 27.3M
- FEMY 25.0M
- IPO Year
- KALA 2017
- FEMY 2021
- Fundamental
- Price
- KALA $7.69
- FEMY $1.14
- Analyst Decision
- KALA Strong Buy
- FEMY Strong Buy
- Analyst Count
- KALA 2
- FEMY 3
- Target Price
- KALA $15.00
- FEMY $10.00
- AVG Volume (30 Days)
- KALA 47.7K
- FEMY 105.5K
- Earning Date
- KALA 11-12-2024
- FEMY 11-12-2024
- Dividend Yield
- KALA N/A
- FEMY N/A
- EPS Growth
- KALA N/A
- FEMY N/A
- EPS
- KALA N/A
- FEMY N/A
- Revenue
- KALA N/A
- FEMY $1,260,643.00
- Revenue This Year
- KALA N/A
- FEMY $157.75
- Revenue Next Year
- KALA N/A
- FEMY $254.07
- P/E Ratio
- KALA N/A
- FEMY N/A
- Revenue Growth
- KALA N/A
- FEMY 15.33
- 52 Week Low
- KALA $4.21
- FEMY $0.73
- 52 Week High
- KALA $8.79
- FEMY $2.40
- Technical
- Relative Strength Index (RSI)
- KALA 61.19
- FEMY 54.27
- Support Level
- KALA $7.00
- FEMY $1.05
- Resistance Level
- KALA $8.79
- FEMY $1.15
- Average True Range (ATR)
- KALA 0.61
- FEMY 0.07
- MACD
- KALA 0.05
- FEMY 0.01
- Stochastic Oscillator
- KALA 51.97
- FEMY 58.82
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.